Khoso Baluch is CEO at CorMedix Inc. (CRMD). They have made 11 open-market trades across 3 companies since 2016, most recently 2026-06-26.
CIK 0001686223
10 open-market purchases totalling $217K since 2016, against 1 sale. Across 10 scored buys the stock is up 11.4% at ninety days, and 2.6 points ahead of the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CRMD | 60,905 | $443K |
| LGVN | 29,415 | $41K |
| PCSA | 2,528 | $4K |
| Total | $488K |
Shares reported on the most recent Form 4, priced at the 2026-06-30 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 40% | 50% |
| Avg Move | +9.4% | -0.3% | +11.4% |
| Alpha | +7.6% | -4.4% | +2.6% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCSA | BUY | 2026-03-31 | 2026-04-01 | $2.54 | $6K | +0.0% | -4.5% | -34.0% |
| LGVN | SELL | 2024-12-02 | 2024-12-04 | $2.07 | $3K | -8.5% | -4.0% | -33.2% |
| LGVN | BUY | 2023-12-28 | 2024-01-02 | $1.42 | $14K | -12.9% | -61.3% | -78.4% |
| CRMD | BUY | 2020-08-13 | 2020-08-17 | $4.14 | $20K | +2.2% | -0.4% | +25.9% |
| CRMD | BUY | 2020-03-18 | 2020-03-18 | $2.61 | $9K | +64.8% | +84.7% | +176.9% |
| CRMD | BUY | 2019-03-26 | 2019-03-27 | $7.55 | $19K | +6.8% | -13.0% | -16.0% |
| CRMD | BUY | 2018-11-26 | 2018-11-27 | $1.22 | $30K | +30.5% | +2.3% | +47.7% |
| CRMD | BUY | 2017-12-12 | 2017-12-14 | $0.48 | $50K | -8.6% | -10.4% | -48.8% |
| CRMD | BUY | 2017-08-18 | 2017-08-22 | $0.42 | $15K | +20.1% | +4.5% | +27.6% |
| CRMD | BUY | 2017-05-17 | 2017-05-19 | $0.48 | $36K | -16.5% | -12.8% | -17.5% |
| CRMD | BUY | 2016-12-09 | 2016-12-13 | $1.77 | $18K | +7.3% | +7.9% | +30.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.